July 8, 2025

The Global Enzyme Linked Immunosorbent Assay Market Driven By Advancements In ELISA Test Kits Is Estimated To Be Valued At US$ 2118.92 Mn In 2023

Enzyme Linked Immunosorbent Assay or ELISA is a biochemical technique used mainly in immunology to detect the presence of antibodies or antigens in a solution. ELISA utilizes an antibody labeled with an enzyme to detect the target antigen or antibody. ELISA tests have become highly effective due to their specificity and accuracy in identifying targets at trace levels. Their wide applications for infectious diseases, autoimmune diseases, cancer screening and other applications have increased their demand substantially. ELISA kits provide fast, cost-effective diagnosis and detection compared to alternatives. Advancement in ELISA kits have made them more sensitive and user-friendly, thus increasing their adoption rate globally.

The global Enzyme Linked Immunosorbent Assay Market is estimated to be valued at US$ 2118.92 Mn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising incidences of chronic and infectious diseases have increased the demand for advanced diagnostic techniques like enzyme immunoassays to rapidly diagnose diseases. With the global burden of diseases rising, there is an urgent need for cost-effective and sensitive diagnostic tools like ELISA tests. Rapid test kits that provide results within 15-30 minutes have gained immense popularity for point-of-care testing and home use. Key market players are engaged in new product launches of rapid ELISA test kits for diseases like HIV, tuberculosis, influenza that can be used in resource-limited settings without advanced laboratory setups. Furthermore, the shift towards miniaturization and automation of ELISA assays have increased throughput and reduced manual errors and testing time per sample. Portable microfluidic ELISA devices are helping decentralized testing and growing the market substantially.

Porter’s Analysis
Threat of new entrants: Enzyme Linked Immunosorbent Assay has high initial capital investments and established brands have an advantage over costs which make it difficult for new companies to enter the market.
Bargaining power of buyers: Buyers have moderate bargaining power due to the availability of substitutes in the market but switching costs are high.
Bargaining power of suppliers: A few large multinational corporations dominate the supply market giving them significant bargaining power over price and quality.
Threat of new substitutes: New technologies like PCR, next generation sequencing pose potential threats, however ELISA is reliable and widely accepted.
Competitive rivalry: The ELISA market is highly competitive with focus on new product innovations and pricing.

Key Takeaways
The global Enzyme Linked Immunosorbent Assay market growth is expected to witness high The global Enzyme Linked Immunosorbent Assay Market is estimated to be valued at US$ 2118.92 Mn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to 2030.

Regional analysis: North America dominated the market in 2023 due to presence of major players in the region and elevated healthcare spending. Asia Pacific is expected to witness highest growth during the forecast period owing to increasing healthcare expenditure, rising awareness and expanding research & development activities in countries like China and India.

Key players operating in the Enzyme Linked Immunosorbent Assay market are Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., R&D Systems, Creative Diagnostics, Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd. Focus on expansion in emerging markets and new product launches is the key strategy adopted by major players.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it

Ravina
+ posts

Ravina Pandya,  Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.

Ravina Pandya

Ravina Pandya,  Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.

View all posts by Ravina Pandya →